Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117296637 | 11729663 | 7 | F | 201104 | 20160718 | 20151112 | 20160725 | EXP | US-DSJP-DSU-2015-121183 | DAIICHI | 0.00 | Y | 0.00000 | 20160725 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117296637 | 11729663 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 20 MG, QD | Y | 21286 | 20 | MG | TABLET | QD | ||||||
| 117296637 | 11729663 | 2 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 20 MG, UNK | Y | 21286 | 20 | MG | TABLET | |||||||
| 117296637 | 11729663 | 3 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 40 MG, QD | Y | 21286 | 40 | MG | TABLET | QD | ||||||
| 117296637 | 11729663 | 4 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG, QD | Y | 21286 | 40 | MG | TABLET | QD | |||||
| 117296637 | 11729663 | 5 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | UNK | Y | 21286 | TABLET | |||||||||
| 117296637 | 11729663 | 6 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | UNK | U | 0 | FILM-COATED TABLET | |||||||||
| 117296637 | 11729663 | 7 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | 10 MG, TID | 0 | 10 | MG | TID | ||||||||
| 117296637 | 11729663 | 8 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 20MG,TID | 0 | 20 | MG | TID | |||||||
| 117296637 | 11729663 | 9 | C | XANAX | ALPRAZOLAM | 1 | 1.5 MG, QD | 0 | 1.5 | MG | QD | ||||||||
| 117296637 | 11729663 | 10 | C | XANAX | ALPRAZOLAM | 1 | Oral | 0.5 MG, TID | 0 | .5 | MG | TID | |||||||
| 117296637 | 11729663 | 11 | C | COLACE | DOCUSATE SODIUM | 1 | 100 MG, PRN | 0 | 100 | MG | |||||||||
| 117296637 | 11729663 | 12 | C | LOMOTIL | ATROPINE SULFATEDIPHENOXYLATE HYDROCHLORIDE | 1 | 2.5-0.025 MG | 0 | 1 | DF | TABLET | ||||||||
| 117296637 | 11729663 | 13 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG, BID | 0 | 20 | MG | CAPSULE | BID | ||||||
| 117296637 | 11729663 | 14 | C | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, QD | 0 | 200 | MG | QD | |||||||
| 117296637 | 11729663 | 15 | C | CELEBREX | CELECOXIB | 1 | 2 MG, BID | 0 | 2 | MG | BID | ||||||||
| 117296637 | 11729663 | 16 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 2.5 MG, QD | 0 | 2.5 | MG | TABLET | QD | ||||||
| 117296637 | 11729663 | 17 | C | VASCEPA | ICOSAPENT ETHYL | 1 | UNK | 0 | |||||||||||
| 117296637 | 11729663 | 18 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 117296637 | 11729663 | 19 | C | ANDROGEL | TESTOSTERONE | 1 | UNK | 0 | GEL |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117296637 | 11729663 | 1 | Hypertension |
| 117296637 | 11729663 | 6 | Product used for unknown indication |
| 117296637 | 11729663 | 7 | Pain |
| 117296637 | 11729663 | 8 | Spinal pain |
| 117296637 | 11729663 | 9 | Post-traumatic stress disorder |
| 117296637 | 11729663 | 11 | Product used for unknown indication |
| 117296637 | 11729663 | 12 | Diarrhoea |
| 117296637 | 11729663 | 13 | Gastrooesophageal reflux disease |
| 117296637 | 11729663 | 14 | Pain |
| 117296637 | 11729663 | 16 | Hypertension |
| 117296637 | 11729663 | 17 | Product used for unknown indication |
| 117296637 | 11729663 | 18 | Product used for unknown indication |
| 117296637 | 11729663 | 19 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117296637 | 11729663 | HO |
| 117296637 | 11729663 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117296637 | 11729663 | Adenoma benign | |
| 117296637 | 11729663 | Anaemia | |
| 117296637 | 11729663 | Chronic obstructive pulmonary disease | |
| 117296637 | 11729663 | Constipation | |
| 117296637 | 11729663 | Enteritis | |
| 117296637 | 11729663 | Haematochezia | |
| 117296637 | 11729663 | Haemorrhoids | |
| 117296637 | 11729663 | Hyperparathyroidism secondary | |
| 117296637 | 11729663 | Intestinal obstruction | |
| 117296637 | 11729663 | Malabsorption | |
| 117296637 | 11729663 | Oesophageal ulcer | |
| 117296637 | 11729663 | Polyp | |
| 117296637 | 11729663 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117296637 | 11729663 | 1 | 201005 | 20110423 | 0 | |
| 117296637 | 11729663 | 2 | 201005 | 20120412 | 0 | |
| 117296637 | 11729663 | 3 | 20110525 | 201402 | 0 | |
| 117296637 | 11729663 | 4 | 20120419 | 201401 | 0 | |
| 117296637 | 11729663 | 6 | 201006 | 0 | ||
| 117296637 | 11729663 | 7 | 2004 | 0 | ||
| 117296637 | 11729663 | 9 | 2004 | 0 | ||
| 117296637 | 11729663 | 11 | 201106 | 0 |